Skip navigation View an alternate layout of this website with limited styles and no horizontal scrolling
Menu

Developments in Research and Technology: The Menniett Device: New Treatment for Meniere's Disease

By Ross, Mark; Hearing Loss Magazine, Vol. 24, No. 2, pp. 33-34
Publication Date: March/April 2003

Article describing the Meniett Low-Pressure Pulse Generator, which is used to treat Meniere’s disease. Meniere’s disease is characterized by sudden attacks of dizziness, often accompanied by nausea, vomiting, a sensation of fullness in one ear, tinnitus, hearing loss, and difficulty in speech discrimination. The Meniett device delivers a controlled series of low-pressure air pulses to the round window membrane leading to cochlea. The energy of the pressure pulses on the round window displaces the inner ear fluids, which leads to an increased flow of fluid within the entire endolymphatic system. This action, in theory, reduces the effects of Meniere’s disease.
Published by: Hearing Loss Association of America (formerly Self Help for Hard of Hearing People)   (Website:http://www.hearingloss.org)

  • Home
  • Alternate Layout
  • My AbleData
  • Contact
  • Site Map
  • A-Z Index
  • Help
  • Privacy

    • AbleData, 8630 Fenton Street, Suite 930, Silver Spring, MD 20910. 1-800-227-0216.
    Maintained for the National Institute on Disability and Rehabilitation Research of the U.S. Dept. of Education
    by ICF Macro under Contract No. ED-04-CO-0018/0007.

    The records in AbleData are provided for information purposes only. Neither the U.S. Department of Education nor ICF Macro has examined, reviewed, or tested any product, device, or information contained in AbleData. The Department and ICF Macro make no endorsement, representation, or warranty express or implied as to any product, device, or information set forth in AbleData. The views expressed on this site do not necessarily represent the opinions of the Department of Education, the National Institute on Disability and Rehabilitation Research, or ICF Macro.